Walleye Capital LLC Acadia Pharmaceuticals Inc Transaction History

Walleye Capital LLC

$24 Billion
Q3 2025

A detailed history of Walleye Capital LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Walleye Capital LLC holds 24,000 shares of ACAD stock, worth $576,480. This represents 0.0% of its overall portfolio holdings.

Number of Shares

24,000

Previous 87,788 72.66%

Holding current value

$576,480

Previous $1.89 Million 72.95%

% of portfolio

0.0%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$14.1 - $22.95 $505,146 - $822,206	35,826 Added 68.95%	87,788 $1.89 Million
Q1 2025 May 14, 2025	SELL	$16.61 - $20.29 $2.09 Million - $2.56 Million	-126,045 Reduced 70.81%	51,962 $863,000
Q4 2024 Feb 13, 2025	BUY	$14.29 - $18.76 $1.96 Million - $2.57 Million	137,201 Added 336.23%	178,007 $3.27 Million
Q3 2024 Nov 14, 2024	SELL	$15.14 - $19.14 $954,183 - $1.21 Million	-63,024 Reduced 60.7%	40,806 $628,000
Q2 2024 Aug 14, 2024	BUY	$14.62 - $18.42 $944,890 - $1.19 Million	64,630 Added 164.87%	103,830 $1.69 Million

Q1 2024 May 15, 2024	SELL	$17.79 - $30.86 $3.62 Million - $6.28 Million	-203,505 Reduced 83.85%	39,200 $724,000
Q4 2023 Feb 14, 2024	BUY	$20.78 - $31.77 $2.99 Million - $4.58 Million	144,104 Added 146.15%	242,705 $7.6 Million
Q3 2023 Nov 14, 2023	BUY	$20.84 - $33.47 $1.56 Million - $2.51 Million	74,850 Added 315.14%	98,601 $2.05 Million
Q2 2023 Aug 14, 2023	SELL	$17.8 - $25.65 $7.03 Million - $10.1 Million	-395,092 Reduced 94.33%	23,751 $568,000
Q1 2023 May 15, 2023	BUY	$16.32 - $20.92 $4.75 Million - $6.09 Million	290,923 Added 227.43%	418,843 $7.88 Million
Q4 2022 Feb 14, 2023	SELL	$14.2 - $18.63 $1.16 Million - $1.52 Million	-81,609 Reduced 38.95%	127,920 $2.04 Million
Q3 2022 Nov 14, 2022	SELL	$14.11 - $18.27 $366,831 - $474,983	-25,998 Reduced 11.04%	209,529 $3.43 Million
Q2 2022 Aug 08, 2022	BUY	$13.01 - $27.22 $2.76 Million - $5.78 Million	212,185 Added 909.03%	235,527 $3.32 Million
Q1 2022 May 16, 2022	SELL	$20.94 - $27.5 $867,607 - $1.14 Million	-41,433 Reduced 63.96%	23,342 $565,000
Q4 2021 Mar 03, 2022	SELL	$16.79 - $27.09 $898,281 - $1.45 Million	-53,501 Reduced 45.23%	64,775 $0
Q3 2021 Nov 15, 2021	BUY	$15.78 - $24.77 $1.57 Million - $2.46 Million	99,276 Added 522.51%	118,276 $1.97 Million
Q2 2021 Aug 16, 2021	BUY	$19.4 - $27.42 $368,600 - $520,980	19,000 New	19,000 $463,000
Q1 2020 May 15, 2020	SELL	$31.65 - $46.87 $26,269 - $38,902	-830 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$36.21 - $51.4 $255,027 - $362,010	-7,043 Reduced 89.46%	830 $36,000
Q3 2019 Nov 14, 2019	BUY	$22.22 - $44.01 $174,938 - $346,490	7,873 New	7,873 $283,000

Others Institutions Holding ACAD

# of Institutions

373

Shares Held

162M

Call Options Held

1.46M

Put Options Held

1.09M

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.89B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Account

Walleye Capital LLC Acadia Pharmaceuticals Inc Transaction History